Monsanto Company (NYSE:MON) was downgraded by stock analysts at Vetr from a “buy” rating to a “hold” rating in a report released on Monday. They currently have a $118.00 price target on the stock. Vetr‘s price objective points to a potential upside of 3.43% from the company’s previous close.
MON has been the subject of several other research reports. CLSA upgraded shares of Monsanto Company from an “underperform” rating to an “outperform” rating in a research report on Friday, January 6th. They noted that the move was a valuation call. Zacks Investment Research cut shares of Monsanto Company from a “buy” rating to a “hold” rating in a research report on Monday, January 9th. Royal Bank of Canada assumed coverage on shares of Monsanto Company in a research report on Thursday, February 23rd. They set a “sector perform” rating and a $118.00 price target for the company. Finally, Sanford C. Bernstein set a $105.00 price objective on shares of Monsanto Company and gave the stock a “neutral” rating in a research note on Thursday, January 5th. Two investment analysts have rated the stock with a sell rating, nine have issued a hold rating and fifteen have assigned a buy rating to the company’s stock. Monsanto Company currently has an average rating of “Buy” and an average target price of $116.15.
Shares of Monsanto Company (NYSE:MON) traded up 0.37% on Monday, hitting $114.09. 2,367,071 shares of the stock traded hands. The firm has a market capitalization of $50.03 billion, a PE ratio of 31.28 and a beta of 0.93. The firm’s 50 day moving average is $111.98 and its 200 day moving average is $106.06. Monsanto Company has a 52 week low of $84.79 and a 52 week high of $116.04.
Monsanto Company (NYSE:MON) last issued its quarterly earnings results on Thursday, January 5th. The company reported $0.21 EPS for the quarter, topping the consensus estimate of $0.01 by $0.20. Monsanto Company had a net margin of 11.61% and a return on equity of 47.05%. The company earned $2.22 billion during the quarter. During the same quarter in the prior year, the firm earned ($0.11) EPS. The firm’s quarterly revenue was up 19.4% compared to the same quarter last year. On average, analysts expect that Monsanto Company will post $4.74 EPS for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, April 28th. Stockholders of record on Friday, April 7th will be given a $0.54 dividend. This represents a $2.16 dividend on an annualized basis and a dividend yield of 1.89%. The ex-dividend date is Wednesday, April 5th. Monsanto Company’s dividend payout ratio is presently 58.86%.
In other news, EVP Steven Mizell sold 2,525 shares of the business’s stock in a transaction on Tuesday, January 10th. The shares were sold at an average price of $108.56, for a total value of $274,114.00. Following the sale, the executive vice president now owns 43,711 shares of the company’s stock, valued at $4,745,266.16. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, CEO Michael K. Stern sold 5,670 shares of the business’s stock in a transaction on Wednesday, January 25th. The stock was sold at an average price of $110.00, for a total transaction of $623,700.00. Following the completion of the sale, the chief executive officer now directly owns 20,534 shares in the company, valued at approximately $2,258,740. The disclosure for this sale can be found here. Insiders own 0.79% of the company’s stock.
Hedge funds have recently made changes to their positions in the company. Mascoma Wealth Management LLC acquired a new stake in shares of Monsanto Company during the fourth quarter worth approximately $115,000. JNBA Financial Advisors raised its stake in shares of Monsanto Company by 24.6% in the fourth quarter. JNBA Financial Advisors now owns 1,148 shares of the company’s stock worth $121,000 after buying an additional 227 shares in the last quarter. First Bank & Trust acquired a new stake in shares of Monsanto Company during the fourth quarter worth approximately $138,000. First Manhattan Co. raised its stake in shares of Monsanto Company by 5.6% in the third quarter. First Manhattan Co. now owns 1,369 shares of the company’s stock worth $139,000 after buying an additional 73 shares in the last quarter. Finally, Israel Discount Bank of New York GFN acquired a new stake in shares of Monsanto Company during the fourth quarter worth approximately $140,000. 75.18% of the stock is currently owned by institutional investors and hedge funds.
About Monsanto Company
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and precision agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
To view Vetr’s full report, visit Vetr’s official website.
Receive News & Ratings for Monsanto Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Company and related companies with MarketBeat.com's FREE daily email newsletter.